Silibinin exerts sustained growth suppressive effect against human colon carcinoma SW480 xenograft by targeting multiple signaling molecules

Pharmaceutical Research

Volumn 27, Issue 10, 2010, Pages 2085-2097

  Velmurugan, Balaiya ^a   Gangar, Subhash Chander ^a   Kaur, Manjinder ^a   Tyagi, Alpna ^a   Deep, Gagan ^a   Agarwal, Rajesh ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

catenin; angiogenesis; colorectal cancer; silibinin; SW480 cells

Indexed keywords

BETA CATENIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; MYC PROTEIN; SILIBININ; SURVIVIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TREATMENT DURATION; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; COLONIC NEOPLASMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, NUDE; SILYMARIN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77957355392     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0207-6     Document Type: Article

References (51)

1. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 10.3322/caac.20006 19474385
2. S Diwanay D Chitre B Patwardhan 2004 Immunoprotection by botanical drugs in cancer chemotherapy J Ethnopharmacol. 90 49 55 10.1016/j.jep.2003.09.023 14698508 (Pubitemid 38091685)
3. B Boursi N Arber 2007 Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention Curr Pharm Des. 13 2274 2282 10.2174/138161207781368783 17692000 1:CAS:528:DC%2BD2sXptl2jt7Y%3D (Pubitemid 47317035)
4. BM Lee KK Park 2003 Beneficial and adverse effects of chemopreventive agents Mutat Res. 523-524 265 278 12628524
5. T Tanaka H Kohno H Mori 2001 Chemoprevention of colon carcinogenesis by dietary non-nutritive compounds Asian Pac J Cancer Prev. 2 165 177 12718627
6. S Rajamanickam R Agarwal 2008 Natural products and colon cancer: current status and future prospects Drug Dev Res. 69 460 471 10.1002/ddr.20276 19884979 1:CAS:528:DC%2BD1MXptVymtQ%3D%3D
7. G Deep R Agarwal 2007 Chemopreventive efficacy of silymarin in skin and prostate cancer Integr Cancer Ther. 6 130 145 10.1177/1534735407301441 17548792 1:CAS:528:DC%2BD2sXnt1Glt7s%3D (Pubitemid 46871840)
8. YJ Surh 2003 Cancer chemoprevention with dietary phytochemicals Nat Rev Cancer. 3 768 780 10.1038/nrc1189 14570043 1:CAS:528:DC%2BD3sXotFChsLw%3D
9. H Wu Q Dai MJ Shrubsole RM Ness D Schlundt WE Smalley H Chen M Li Y Shyr W Zheng 2009 Fruit and vegetable intakes are associated with lower risk of colorectal adenomas J Nutr. 139 340 344 19091801 1:CAS:528:DC%2BD1MXht1WntLk%3D
10. RP Singh M Gu R Agarwal 2008 Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis Cancer Res. 68 2043 2050 10.1158/0008-5472.CAN-07-6247 18339887 1:CAS:528:DC%2BD1cXjtFOht7o%3D (Pubitemid 351416592)
11. M Kaur B Velmurugan A Tyagi G Deep S Katiyar C Agarwal R Agarwal 2009 Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft Mol Cancer Ther. 8 2366 2374 10.1158/1535-7163.MCT-09-0304 19638451 1:CAS:528:DC%2BD1MXpvFCms74%3D
12. RP Singh K Raina G Sharma R Agarwal 2008 Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial-mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice Clin Cancer Res. 14 7773 7780 10.1158/1078-0432.CCR-08-1309 19047104 1:CAS:528:DC%2BD1cXhsVegtrfO
13. RD Verschoyle P Greaves K Patel DA Marsden K Brown WP Steward AJ Gescher 2008 Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels Eur J Cancer. 44 898 906 10.1016/j.ejca.2008.02.020 18343654 1:CAS:528:DC%2BD1cXks1Gmsrc%3D
14. RP Singh G Deep M Chittezhath M Kaur LD Dwyer-Nield AM Malkinson R Agarwal 2006 Effect of silibinin on the growth and progression of primary lung tumors in mice J Natl Cancer Inst. 98 846 855 10.1093/jnci/djj231 16788158 1:CAS:528:DC%2BD28Xmt1Wktr4%3D (Pubitemid 43923441)
15. C Agarwal RP Singh S Dhanalakshmi AK Tyagi M Tecklenburg RA Sclafani R Agarwal 2003 Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells Oncogene. 22 8271 8282 10.1038/sj.onc.1207158 14614451 1:CAS:528:DC%2BD3sXovVyms7c%3D (Pubitemid 37485520)
16. FS Hogan NK Krishnegowda M Mikhailova MS Kahlenberg 2007 Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer J Surg Res. 143 58 65 10.1016/j.jss.2007.03.080 17950073 1:CAS:528:DC%2BD2sXhtF2htrfP (Pubitemid 47562449)
17. S Rajamanickam M Kaur B Velmurugan RP Singh R Agarwal 2009 Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway Pharm Res. 26 2558 2567 10.1007/s11095-009-9968-1 19779968 1:CAS:528:DC%2BD1MXhtlCrtb7K
18. B Velmurugan RP Singh A Tyagi R Agarwal 2008 Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats Cancer Prev Res (Phila Pa) 1 376 384 1:CAS:528: DC%2BC3cXptFOit7w%3D
19. N Sangeetha AJ Felix N Nalini 2009 Silibinin modulates biotransforming microbial enzymes and prevents 1, 2-dimethylhydrazine-induced preneoplastic changes in experimental colon cancer Eur J Cancer Prev. 18 385 394 10.1097/CEJ.0b013e32832d1b4f 19654488 1:CAS:528:DC%2BD1MXhtV2itLnO
20. A Herbst FT Kolligs 2007 Wnt signaling as a therapeutic target for cancer Methods Mol Biol. 361 63 91 17172707 1:CAS:528:DC%2BD2sXmslChtw%3D%3D
21. FE Ahmed 2003 Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 21 65 131 15845222
22. Y Yamada H Mori 2007 Multistep carcinogenesis of the colon in Apc(Min/+) mouse Cancer Sci. 98 6 10 10.1111/j.1349-7006.2006.00348.x 17052257 1:CAS:528:DC%2BD2sXht1Gisrg%3D (Pubitemid 44803913)
23. W de Lau N Barker H Clevers 2007 WNT signaling in the normal intestine and colorectal cancer Front Biosci. 12 471 491 10.2741/2076 17127311 (Pubitemid 46852800)
24. M van de Wetering E Sancho C Verweij W de Lau I Oving A Hurlstone K van der Horn E Batlle D Coudreuse AP Haramis M Tjon-Pon-Fong P Moerer M van den Born G Soete S Pals M Eilers R Medema H Clevers 2002 The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells Cell. 111 241 250 10.1016/S0092-8674(02)01014-0 12408868 (Pubitemid 35292444)
25. J Schneikert J Behrens 2007 The canonical Wnt signalling pathway and its APC partner in colon cancer development Gut. 56 417 425 10.1136/gut.2006.093310 16840506 1:CAS:528:DC%2BD2sXksVCqs70%3D (Pubitemid 46579774)
26. J Yang W Zhang PM Evans X Chen X He C Liu 2006 Adenomatous polyposis coli (APC) differentially regulates beta-catenin phosphorylation and ubiquitination in colon cancer cells J Biol Chem. 281 17751 17757 10.1074/jbc.M600831200 16798748 1:CAS:528:DC%2BD28XmtFyksbs%3D (Pubitemid 44035574)
27. N Shimazaki T Yazaki T Kubota A Sato A Nakamura S Kurei S Toji K Tamai O Koiwai 2005 DNA polymerase lambda directly binds to proliferating cell nuclear antigen through its confined C-terminal region Genes Cells. 10 705 715 10.1111/j.1365-2443.2005.00868.x 15966901 1:CAS:528:DC%2BD2MXpvF2ltr0%3D (Pubitemid 40932350)
28. V Prasad A Chandele JC Jagtap P Sudheer Kumar P Shastry 2006 ROS-triggered caspase 2 activation and feedback amplification loop in beta-carotene-induced apoptosis Free Radic Biol Med. 41 431 442 10.1016/j.freeradbiomed.2006.03.009 16843824 1:CAS:528:DC%2BD28XntFWru7s%3D (Pubitemid 44056011)
29. TC He AB Sparks C Rago H Hermeking L Zawel LT da Costa PJ Morin B Vogelstein KW Kinzler 1998 Identification of c-MYC as a target of the APC pathway Science. 281 1509 1512 10.1126/science.281.5382.1509 9727977 1:CAS:528:DyaK1cXlvFGntr0%3D (Pubitemid 28425575)
30. V Easwaran SH Lee L Inge L Guo C Goldbeck E Garrett M Wiesmann PD Garcia JH Fuller V Chan F Randazzo R Gundel RS Warren J Escobedo SL Aukerman RN Taylor WJ Fantl 2003 beta-Catenin regulates vascular endothelial growth factor expression in colon cancer Cancer Res. 63 3145 3153 12810642 1:CAS:528:DC%2BD3sXks1eitbc%3D
31. Q Du KS Park Z Guo P He M Nagashima L Shao R Sahai DA Geller SP Hussain 2006 Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling Cancer Res. 66 7024 7031 10.1158/0008-5472.CAN-05-4110 16849547 1:CAS:528:DC%2BD28XmvFGktrg%3D (Pubitemid 44197678)
32. T Zhang T Otevrel Z Gao SM Ehrlich JZ Fields BM Boman 2001 Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer Cancer Res. 61 8664 8667 11751382 1:CAS:528:DC%2BD38Xht1OgsQ%3D%3D
33. H Huang X He 2008 Wnt/beta-catenin signaling: new (and old) players and new insights Curr Opin Cell Biol. 20 119 125 10.1016/j.ceb.2008.01.009 18339531 1:CAS:528:DC%2BD1cXks1Gnur8%3D
34. QL Liang BR Wang GH Li 2009 DcR3 and survivin are highly expressed in colorectal carcinoma and closely correlated to its clinicopathologic parameters J Zhejiang Univ Sci B. 10 675 682 10.1631/jzus.B0920077 19735100 1:CAS:528:DC%2BD1MXhtVygsr%2FJ
35. R Nusse 2005 Wnt signaling in disease and in development Cell Res. 15 28 32 10.1038/sj.cr.7290260 15686623 1:CAS:528:DC%2BD2MXkslGisb0%3D (Pubitemid 41653961)
36. EV Schmidt 1999 The role of c-myc in cellular growth control Oncogene. 18 2988 2996 10.1038/sj.onc.1202751 10378694 1:CAS:528:DyaK1MXjs12qtLo%3D (Pubitemid 29276538)
37. R Gianani E Jarboe D Orlicky M Frost J Bobak R Lehner KR Shroyer 2001 Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa Hum Pathol. 32 119 125 10.1053/hupa.2001.21897 11172305 1:CAS:528: DC%2BD3MXjslKmtbs%3D (Pubitemid 32150638)
38. D Liao RS Johnson 2007 Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev. 26 281 290 10.1007/s10555-007-9066-y 17603752 1:CAS:528:DC%2BD2sXotFWrtLw%3D (Pubitemid 47101669)
39. DL Bemis AE Katz R Buttyan 2006 Clinical trials of natural products as chemopreventive agents for prostate cancer Expert Opin Investig Drugs. 15 1191 1200 10.1517/13543784.15.10.1191 16989596 1:CAS:528:DC%2BD28XpvVeisLc%3D (Pubitemid 44608259)
40. H Kawasaki DC Altieri CD Lu M Toyoda T Tenjo N Tanigawa 1998 Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res. 58 5071 5074 9823313 1:CAS:528:DyaK1cXnsFSmt78%3D
41. J Folkman 2007 Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 6 273 286 10.1038/nrd2115 17396134 1:CAS:528: DC%2BD2sXjs1SisL4%3D (Pubitemid 46505878)
42. P Carmeliet RK Jain 2000 Angiogenesis in cancer and other diseases Nature. 407 249 257 10.1038/35025220 11001068 1:CAS:528:DC%2BD3cXmvVSls74%3D
43. AF Karamysheva 2008 Mechanisms of angiogenesis Biochemistry (Mosc) 73 751 762 10.1134/S0006297908070031 1:CAS:528:DC%2BD1cXpt12rtLw%3D
44. LM Ellis Y Takahashi W Liu RM Shaheen 2000 Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications Oncologist 5 Suppl 1 11 15 10.1634/theoncologist.5-suppl-1-11 10804085 1:CAS:528: DC%2BD3cXjsFartr0%3D
45. RS Warren H Yuan MR Matli NA Gillett N Ferrara 1995 Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis J Clin Invest. 95 1789 1797 10.1172/JCI117857 7535799 1:CAS:528:DyaK2MXkslyktb4%3D
46. ER Cullis TL Kalber SE Ashton JE Cartwright JR Griffiths AJ Ryan SP Robinson 2006 Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126 Microvasc Res. 71 76 84 10.1016/j.mvr.2006.01.004 16530791 1:CAS:528:DC%2BD28XjvVGlsrg%3D
47. F Cianchi C Cortesini O Fantappie L Messerini I Sardi N Lasagna F Perna V Fabbroni A Di Felice G Perigli R Mazzanti E Masini 2004 Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer Clin Cancer Res. 10 2694 2704 10.1158/1078-0432.CCR-03-0192 15102673 1:CAS:528:DC%2BD2cXjt1CltLw%3D (Pubitemid 38509144)
48. MP Correa Lima MH Gomes-da-Silva 2005 Colorectal cancer: lifestyle and dietary factors Nutr Hosp. 20 235 241 16045124 1:STN:280:DC%2BD2Mzos12ktA%3D%3D
49. EJ Ladas KM Kelly 2003 Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer? J Altern Complement Med. 9 411 416 10.1089/107555303765551633 12816629
50. C Hoh D Boocock T Marczylo R Singh DP Berry AR Dennison D Hemingway A Miller K West S Euden G Garcea PB Farmer WP Steward AJ Gescher 2006 Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences Clin Cancer Res. 12 2944 2950 10.1158/1078-0432. CCR-05-2724 16675592 1:CAS:528:DC%2BD28Xltlamurs%3D
51. TW Flaig M Glodé D Gustafson A van Bokhoven Y Tao S Wilson LJ Su Y Li G Harrison R Agarwal ED Crawford MS Lucia M Pollak 2010 A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer Prostate. 70 848 855 20127732 1:CAS:528:DC%2BC3cXnvFGqs7o%3D